Navigation Links
Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
Date:10/8/2009

ing 66 percent, up from 50 percent between 1975-77.

Nearly all the cancer drugs approved by the Food and Drug Administration in the last four years have cost more than $20,000 for a twelve-week course of therapy, while some individual treatments can cost $10,000 per month. Oncology drugs are projected to account for 9 percent of all prescription pharmaceutical spending growth between 2009 and 2011.

To help manage the drug spend in the biotech drug category, in which many of the cancer treatments reside, a regulatory pathway to make lower-cost, generic versions - biosimilars - of these drugs is now under consideration in Congress. If approved, generic biotech drugs could lead to significant savings once the original brand drug loses patent.

Breast cancer drugs to hit market

Many oncology agents in late stage clinical development and several expected to receive approval in 2010 or 2011 will likely have a significant effect on specialty drug spending. Breast cancer could have an array of new treatments, including vandetanib (Zactima(TM)), motesanib, lonafarnib (Sarasar®), and pazopanib. Several of these drugs may be initially approved for other forms of cancer.

Supportive Care

Supportive care therapies that help manage the side effects of other cancer treatments represent a considerable share of cancer-related drug costs. In the case of side effects from breast cancer treatment, several treatments that suppress estrogen can contribute to the risk for osteoporosis, and oral or injectable osteoporosis drugs can reduce the risk of skeletal problems and bony metastasis. Chemotherapy and radiation treatments can create additional side effects and new drugs have entered the market to treat those problems. Drugs to treat anemia and neutropenia, both side effects associated with chemotherapy, have been on the market for years. However, supportive care therapies need speci
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
2. Oral Cancer Foundation to Donate Screening Devices to Free Clinics
3. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
4. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
5. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
6. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer
9. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
11. Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... Aug. 29, 2014 Diseases largely eradicated in ... ago are returning. Measles was declared eliminated in 2000, ... as of August 15—the highest incidence in 20 years. ... department declared whooping cough a problem of "epidemic ... sick and dying from these preventable diseases—in part because ...
(Date:8/29/2014)... 2014 Research and Markets has ... Drugs Market 2014-2018" report to their offering. ... condition that results in demyelination, axonal transection, and neurodegeneration. ... response by the immune system, which targets neurons within ... debilitating disease in which the damage of the myelin ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... China, April 16, 2011 China Medical Equipment ... provider of ultrasound and MRI systems in China, ... portable ultrasound machine. The iuStar100 utilizes Samplify,s high-performance, ... SAM1600 analog to digital converter (ADC) to deliver ...
... Md., April 15, 2011 The U.S. Food and ... or in combination with methotrexate, for the treatment ... children ages 2 years and older. ... Still,s disease, is a rare, potentially life-threatening disorder ...
Cached Medicine Technology:United Imaging Healthcare Leverages Samplify's Analog Front-End Solutions to Deliver New Portable Ultrasound System with Superior Image Quality 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Developers and ... announced a new ProIntro Lesson from Pixel Film Studios. ... easy and fresh-looking titles,” said Christina Austin, CEO of ... armature, ProIntro is a definite game changer.” , Learn ... ProIntro Lesson from Pixel Film Studios. ProIntro is a ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 NOVAtime ... Management solution development company, announced today that Avon ... 2009, has upgraded to NOVAtime 4000 Time ... conjunction with NOVAtime’s latest smart clock, the ... Farmington Valley of Connecticut is an award-winning nursing ...
(Date:9/2/2014)... 02, 2014 “Harmonicas have been ... decade, primarily to help people with COPD or ... three developed systems,” says Dana Keller, PhD, co-inventor ... the goals are much the same – improved ... type of harmonica.” , The three approaches to ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 September 2014 – ... long gone. But even though men shave daily – and ... – rough and irritated skin isn’t inevitable, according to ... P.C. , For decades, skin care was something in ... a surge in men of all ages who realize that ...
(Date:9/2/2014)... AURO the enterprise Canadian Public ... expansion of its leadership team with the appointment of ... Liang joins AURO in conjunction with his current role ... with the operations, product management and engineering teams to ... well as ensuring effective internal and external controls are ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 3Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3
... following Hurricane Katrina, the health of survivors 65 and ... sample of older adults not affected by the disaster, ... Johns Hopkins Bloomberg School of Public Health. The August ... deadliest hurricanes in U.S. history. Hurricane Katrina displaced thousands ...
... This release is available in French . ... study of its kind on preschoolers has demonstrated that ... effective in reducing the severity and duration of asthma ... of clinical research at the Sainte-Justine Hospital Research Center ...
... -- Stern Communications, a public ... its new client www.healthcarebluebook.com . The start-up ... their zip code for healthcare services. Stern Communications ... into strategic communications resources and campaigns aimed at ...
... Jan. 22 Hillenbrand, Inc.,(NYSE: HI ) ... Thursday, Feb. 5, 2009. The full text of the ... site at www.HillenbrandInc.com . , ... simultaneous webcast with,investors and financial analysts that day at ...
... - Engineers at Purdue and Stanford universities have created ... and other cells react to mechanical stresses from heart ... devices are made by injecting a liquid alloy made ... sheets of a plastic polymer, said Babak Ziaie, a ...
... release is available in Spanish . , ... for detecting the presence of Salmonella spp. and ... time than current systems. Unlike others, this project used clinical ... new diagnostic device is effectively a miniature conventional laboratory inside ...
Cached Medicine News:Health News:Decline in health among older adults affected by Hurricane Katrina 2Health News:New treatment reduces severity of asthma attacks in preschoolers 2Health News:Stern Communications Wins and Helps Launch Healthcarebluebook.com 2Health News:New stretchable electrodes created to study stresses on cardiac cells 2Health News:IK4 develops a portable device for detecting Salmonella in under an hour 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: